Skip to main content
. 2023 May 17;11:1170025. doi: 10.3389/fped.2023.1170025

Table 3.

Patients and number of symptoms during period study stratified by treatment.

N. symptoms Leuprolide
N = 48 (%)
Triptorelin
N = 62 (%)
Total
N = 110 (%)
0 29 (60.4) 35 (56.4) 64 (58.2)
1 9 (18.8) 18 (29.0) 27 (24.5)
2 5 (10.4) 5 (8.1) 10 (9.1)
≥3 5 (10.4) 4 (6.5) 9 (8.2)